Company Description
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally.
It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals.
It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill’s Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill’s Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand.
This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers.
Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
| Country | United States |
| Founded | 1806 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 33,600 |
| CEO | Noel Wallace |
Contact Details
Address: 300 Park Avenue New York, New York 10022-7499 United States | |
| Phone | 212 310 2000 |
| Website | colgatepalmolive.com |
Stock Details
| Ticker Symbol | CL |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000021665 |
| CUSIP Number | 194162103 |
| ISIN Number | US1941621039 |
| Employer ID | 13-1815595 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Noel R. Wallace | Chairman, Chief Executive Officer and President |
| Stanley J. Sutula III | Chief Financial Officer |
| Jennifer M. Daniels | Chief Legal Officer and Secretary |
| Panagiotis Tsourapas | Chief Operating Officer of Europe, Asia Pacific, Africa Eurasia and Skin Health & Global Customer Dev. |
| Shane Grant | Chief Operating Officer of Americas |
| Stephan Habif | Chief Technology Officer |
| David Foster | Chief Information Officer |
| John Faucher | Chief Investor Relations Officer and Executive Vice President of M&A |
| Eutychus Karuru | Executive Vice President of Internal Audit and Compliance |
| Dana Bolden | Chief Communications Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 9, 2026 | 8-K | Current Report |
| Mar 26, 2026 | SCHEDULE 13G/A | Filing |
| Mar 25, 2026 | ARS | Filing |
| Mar 25, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 25, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 17, 2026 | 8-K | Current Report |
| Mar 12, 2026 | 8-K | Current Report |
| Mar 6, 2026 | 25-NSE | Filing |
| Feb 23, 2026 | 10-K | Annual Report |
| Feb 12, 2026 | 144 | Filing |